Catalyst Event
Eli Lilly and Co (LLY) · Other
From KEDI U.S. Quality500 + Monthly 1% Premium Index(NTR) (KUSQL500P)
6/8/2026, 12:00:00 AM
Eli Lilly presented positive new data from two Phase 3 trials for its next-generation obesity drug, retatrutide, at the American Diabetes Association meeting, showing significant weight loss.
Korean Translation
일라이 릴리가 미국 당뇨병 학회에서 차세대 비만 치료제 레타트루타이드의 2건의 3상 임상시험에서 상당한 체중 감소를 보인 긍정적인 신규 데이터를 발표함.
Related Recent Events
Snowflake Inc (SNOW) · Earnings Release
Snowflake's next earnings release for Q2 fiscal year 2027 is scheduled for August 26, 2026, scheduled. This event is expected to have a medium impact as earnings reports typically drive price movements of at least 5%.
8/26/2026, 12:00:00 AM
Applied Materials Inc (AMAT) · Other
A quarterly dividend of $0.53 per share is expected, with an ex-dividend date of August 20, 2026. Low importance is assigned as standard dividend events typically result in a <5% price impact, expected.
8/20/2026, 12:00:00 AM
Home Depot Inc. (The) (HD) · Earnings Release
Q2 2026 earnings release and conference call on August 18, 2026, with medium importance estimated due to typical market volatility following results, scheduled.
8/18/2026, 12:00:00 AM
Keysight Technologies Inc (KEYS) · Earnings Release
Keysight's fiscal Q3 2026 earnings release is scheduled. Importance is estimated as Medium based on historical price volatility around earnings dates, scheduled.
8/18/2026, 12:00:00 AM
Applied Materials Inc (AMAT) · Earnings Release
The Q3 2026 earnings release is scheduled for August 13, 2026. Low importance is assigned as the announcement of a reporting date typically has a <5% price impact, scheduled.
8/13/2026, 12:00:00 AM
Cisco Systems Inc (CSCO) · Earnings Release
Cisco is scheduled to release its Q4 and full fiscal year 2026 earnings on August 12, 2026, scheduled. Market reaction estimated at ≥5% based on historical earnings volatility.
8/12/2026, 12:00:00 AM